Genome Wide Association Study for Predictors of Progression Free Survival in Patients on Capecitabine, Oxaliplatin, Bevacizumab and Cetuximab in First-Line Therapy of Metastatic Colorectal Cancer.

PLoS One · 2015 · PMC4519298 · PMID 26222057

Europe PMC DOI

hedged sentence

0.0000

closest p · 0.0× alpha

0.0000

boldest claim

The sentences

highly significantP = 2.17x10 -8actually significant

One marker (rs885036, position 98671226) on chromosome 2q12 showed a highly significant interaction with treatment arm (P = 2.17x10 -8 ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.